C49.A4
Gastrointestinal stromal tumor of large intestine
Clinical Classification Guidelines
Medical Intelligence & Overview
A gastrointestinal stromal tumor (GIST) of the large intestine is a rare type of growth that occurs in the digestive tract's wall, specifically within the large intestine or colon. These tumors originate from specialized cells called interstitial cells of Cajal, which help regulate intestinal movements. GISTs can be benign or malignant, with their behavior varying based on factors like size and mitotic activity. Understanding this condition involves recognizing potential causes, symptoms, diagnostic procedures, and available treatments.
Causes & Symptoms
Clinical Causes: Mutations in genes such as KIT or PDGFRA that lead to abnormal cell growth Genetic predispositions that may increase susceptibility Rarely, previous exposure to certain chemicals or radiation
Key Symptoms: Persistent abdominal discomfort or pain Changes in bowel habits, such as diarrhea or constipation Rectal bleeding or blood in stool A noticeable lump or mass in the abdomen Unexplained weight loss Feeling of fullness or early satiety Nausea or vomiting in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing a gastrointestinal stromal tumor of the large intestine involves several steps: - **Medical history and physical examination** to assess symptoms and detect any palpable masses. - **Imaging tests**, such as CT scans or MRI, to identify the location and size of the tumor. - **Endoscopic procedures**, like colonoscopy, to visualize the tumor directly and obtain tissue samples through biopsy. - **Histopathological analysis** to examine the tissue under a microscope. - **Molecular testing** for mutations in KIT or PDGFRA genes, which can guide treatment options. Accurate diagnosis is essential for determining the nature of the tumor and planning appropriate management strategies.
Treatment Protocols: Treatment options for a gastrointestinal stromal tumor of the large intestine depend on the tumor's size, location, and whether it has spread: - **Surgical removal** is often the primary approach, aiming to excise the tumor completely while preserving as much normal tissue as possible. - **Targeted therapy** with medications like imatinib may be prescribed, especially if the tumor is malignant or unresectable, as these drugs can inhibit specific mutated proteins involved in tumor growth. - **Monitoring and follow-up** are vital to detect any recurrence or metastasis, involving regular imaging and clinical examinations. - **Additional therapies**, such as chemotherapy or radiation, are generally less effective but may be considered in specific cases. A multidisciplinary medical team will tailor the treatment plan based on individual patient factors.
Clinical Advice & FAQs
Billing Guidance
Is C49.A4 a billable ICD-10 code?
Yes, C49.A4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C49.A4?
Clinical documentation must specify the nature of Gastrointestinal stromal tumor of large intestine and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
